These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20497188)

  • 21. A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour.
    Doan T; Herd K; Ramshaw I; Thomson S; Tindle RW
    Cancer Immunol Immunother; 2005 Feb; 54(2):157-71. PubMed ID: 15480657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
    Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inducement of cytotoxic T cell responses in mice by constructing a multi-CTL epitope-based DNA vaccine].
    Shi L; Yuan YK; Sheng L; Fan GX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):430-2. PubMed ID: 16806000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.
    Wild J; Bojak A; Deml L; Wagner R
    Vaccine; 2004 Apr; 22(13-14):1732-43. PubMed ID: 15068857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine.
    Kim JJ; Trivedi NN; Wilson DM; Mahalingam S; Morrison L; Tsai A; Chattergoon MA; Dang K; Patel M; Ahn L; Boyer JD; Chalian AA; Schoemaker H; Kieber-Emmons T; Agadjanyan MA; Weiner DB
    Oncogene; 1998 Dec; 17(24):3125-35. PubMed ID: 9872328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
    Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
    J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus.
    Pack CD; Kumaraguru U; Suvas S; Rouse BT
    Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.
    Natuk RJ; Cooper D; Guo M; Calderon P; Wright KJ; Nasar F; Witko S; Pawlyk D; Lee M; DeStefano J; Tummolo D; Abramovitz AS; Gangolli S; Kalyan N; Clarke DK; Hendry RM; Eldridge JH; Udem SA; Kowalski J
    J Virol; 2006 May; 80(9):4447-57. PubMed ID: 16611905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
    Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
    J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune response and protective efficacy in BALB/c mice induced by DNA vaccine encoding immunogenic protein of Legionella pneumophila].
    Yang ZW; Chen JP; Wang T; Tian Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):209-12. PubMed ID: 17343784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.
    Muller WJ; Dong L; Vilalta A; Byrd B; Wilhelm KM; McClurkan CL; Margalith M; Liu C; Kaslow D; Sidney J; Sette A; Koelle DM
    J Gen Virol; 2009 May; 90(Pt 5):1153-1163. PubMed ID: 19264627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Construction and immunogenic study of recombinant adenovirus containing chimeric gene G2S0.7 and CTL epitopes of Hantaan virus].
    Hu G; Bai WT; Wu XA; Wang HT; Xu ZK; Zhang FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1070-4. PubMed ID: 21055343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.
    Goel N; Rong Q; Zimmerman D; Rosenthal KS
    Vaccine; 2003 Oct; 21(27-30):4410-20. PubMed ID: 14505924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.